Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

about

Correction to: Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

P2860

Q55038992-4F9490A2-5601-4398-A6B8-E8851F9DA11E

P2860

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

Item

http://www.wikidata.org/entity/Q49344856

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@en

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@nl

type

Item

label

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@en

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@nl

prefLabel

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@en

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

@nl

P1476

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM

@en

P2093

Julia K Langer

http://www.w3.org/2001/XMLSchema#string

Kevin Oneill

http://www.w3.org/2001/XMLSchema#string

Lina Mörén

http://www.w3.org/2001/XMLSchema#string

Nelofer Syed

http://www.w3.org/2001/XMLSchema#string

Richard Perryman

http://www.w3.org/2001/XMLSchema#string

Tim Crook

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle

Metabolomics--the link between genotypes and phenotypes

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Chemometrics in metabonomics.

Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis.

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.

Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors

Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry.

Malignant glioma: genetics and biology of a grave matter.

P2888

s12885-018-4040-3

P304

167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4040-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Antti

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100915825

http://www.w3.org/2001/XMLSchema#string

P698

29422017

http://www.w3.org/2001/XMLSchema#string

P932

5806242

http://www.w3.org/2001/XMLSchema#string

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

about

P2860

P2860

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932